12:00 AM
 | 
Nov 22, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Enbrel etanercept: Marketed

In 480 patients treated with Enbrel for 1 year, 72, 47 and 21 percent achieved ACR 20, 50 and 70 responses, respectively. Data from 83 patients treated...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >